Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.
Shares of Quest Diagnostics Inc. (DGX) rose 2.58% to $194.20 on a strong trading day, outperforming competitors like UnitedHealth Group Inc. (UNH) and Centene Corp. (CNC). The S&P 500 Index increased by 1.02%, while the Dow Jones Industrial Average rose by 1.62%. Despite the gain, Quest Diagnostics remains 9.04% below its 52-week high of $213.50 reached on February 27th. Trading volume was 1.1 million, surpassing the 50-day average of 926,887 shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments